Last reviewed · How we verify

Biological mesh — Competitive Intelligence Brief

Biological mesh (Biological mesh) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Biological scaffold/tissue engineering product. Area: Surgery/Tissue Repair.

phase 3 Biological scaffold/tissue engineering product Surgery/Tissue Repair Biologic Live · refreshed every 30 min

Target snapshot

Biological mesh (Biological mesh) — University Hospital, Lille. Biological mesh provides structural support and promotes tissue integration through naturally-derived or bioengineered extracellular matrix material.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Biological mesh TARGET Biological mesh University Hospital, Lille phase 3 Biological scaffold/tissue engineering product

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Biological scaffold/tissue engineering product class)

  1. University Hospital, Lille · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Biological mesh — Competitive Intelligence Brief. https://druglandscape.com/ci/biological-mesh. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: